E5

Welcome to the Brand page for “E5”, which is offered here for Antiendotoxin antibodies for treatment of septic shock and related conditions;.

Its status is currently believed to be active. Its class is unavailable. “E5” is believed to be currently owned by “Pfizer Inc.”

Owner:
PFIZER INC.
Owner Details
Description:
ANTIENDOTOXIN ANTIBODIES FOR TREATMENT OF SEPTIC SHOCK AND RELATED CONDITIONS;
Categories: ANTIENDOTOXIN ANTIBODIES FOR TREATMENT